ARTICLE | Clinical News
Amgen Inc. (AMGN) preclinical data
July 31, 1995 7:00 AM UTC
Amgen researchers published studies in mice that show the ob gene product can reverse the obesity and metabolic defects present with the mutated gene. As reported in Science, the human ob gene product also was effective in correcting the gene defect in mice. ...